Accuray Incorporated (ARAY) News
Filter ARAY News Items
ARAY News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ARAY News Highlights
- ARAY's 30 day story count now stands at 3.
- Over the past 1 day, the trend for ARAY's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- GAME, HD and TOP are the most mentioned tickers in articles about ARAY.
Latest ARAY News From Around the Web
Below are the latest news stories about ACCURAY INC that investors may wish to consider to help them evaluate ARAY as an investment opportunity.
Accuray (ARAY) Launches VitalHold in Japan for Use With RadixactAccuray's (ARAY) VitalHold is likely to transform breast cancer treatment in Japan by integrating SGRT for precise radiotherapy. It may become a game-changer for patients and medical staff. |
Accuray Initiates Sales of the VitalHold™ Solution in Japan, Supporting Surface-guided Radiation Therapy on the Radixact® SystemAccuray Incorporated (NASDAQ: ARAY) announced today that the company has initiated sales of the VitalHold™* package supporting surface-guided radiation therapy (SGRT) on the Radixact® System in Japan beginning November 30, 2023. The VitalHold feature incorporates SGRT capability on the Radixact System using the Catalyst+ HD system manufactured by C-RAD, making it possible to deliver deep inspiration breath hold (DIBH) treatments, primarily for breast cancers, and perform markerless patient setup |
Insider Sell Alert: President Suzanne Winter Sells 65,390 Shares of Accuray Inc (ARAY)Accuray Incorporated (NASDAQ:ARAY), a company specializing in the development, manufacturing, and selling of radiotherapy systems for alternative cancer treatments, has recently witnessed a significant insider sell from one of its top executives. |
Accuray Incorporated (NASDAQ:ARAY) Q1 2024 Earnings Call TranscriptAccuray Incorporated (NASDAQ:ARAY) Q1 2024 Earnings Call Transcript November 7, 2023 Accuray Incorporated reports earnings inline with expectations. Reported EPS is $-0.03 EPS, expectations were $-0.03. Operator: Good afternoon and welcome to the Accuray’s First Quarter 2024 Conference Call. [Operator Instructions] Please note that this event is being recorded. I would now like to turn […] |
Accuray (ARAY) Q1 Earnings In-Line With Estimates, Revenues TopAccuray (ARAY) reports a solid fiscal first quarter top line on the back of robust Product revenues. |
Q1 2024 Accuray Inc Earnings CallQ1 2024 Accuray Inc Earnings Call |
Compared to Estimates, Accuray (ARAY) Q1 Earnings: A Look at Key MetricsThe headline numbers for Accuray (ARAY) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
Accuray Reports Fiscal 2024 First Quarter Financial ResultsAccuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter of fiscal 2024 ended September 30, 2023. |
Accuray to Participate in the 14th Annual Jefferies London Healthcare ConferenceAccuray Incorporated (NASDAQ: ARAY) announced today its participation in the 14th Annual Jefferies London Healthcare Conference. The management team is scheduled to participate in a presentation with moderated Q&A on Wednesday, November 15th, 2023 at 9:00am GMT/4:00am EST. |
The past five years for Accuray (NASDAQ:ARAY) investors has not been profitableIdeally, your overall portfolio should beat the market average. But even the best stock picker will only win with some... |